69 related articles for article (PubMed ID: 27292155)
1. Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer.
Filippi A; Aurelian J; Mocanu MM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612439
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Role of Surface and Mitochondrial ATP-Sensitive Potassium Channels in Cancer: From Cellular Functions to Therapeutic Potentials.
Moon DO
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396807
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
Biomed Pharmacother; 2024 Jan; 170():116013. PubMed ID: 38104416
[TBL] [Abstract][Full Text] [Related]
4. Gliclazide Reduces Colitis-Associated Colorectal Cancer Formation by Deceasing Colonic Inflammation and Regulating AMPK-NF-κB Signaling Pathway.
Li S; Wang Y; Zhang D; Wang H; Cui X; Zhang C; Xin Y
Dig Dis Sci; 2024 Feb; 69(2):453-462. PubMed ID: 38103106
[TBL] [Abstract][Full Text] [Related]
5. Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer.
Malik JA; Ahmed S; Momin SS; Shaikh S; Alafnan A; Alanazi J; Said Almermesh MH; Anwar S
ACS Omega; 2023 Jan; 8(1):56-73. PubMed ID: 36643505
[TBL] [Abstract][Full Text] [Related]
6. Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.
Bahmad HF; Demus T; Moubarak MM; Daher D; Alvarez Moreno JC; Polit F; Lopez O; Merhe A; Abou-Kheir W; Nieder AM; Poppiti R; Omarzai Y
Med Sci (Basel); 2022 Feb; 10(1):. PubMed ID: 35225948
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone.
Yang L; Ge Q; Ye Z; Wang L; Wang L; Mashrah MA; Pathak JL
Front Pharmacol; 2021; 12():728458. PubMed ID: 34539410
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Anti-Diabetic Drugs on Prostate Cancer.
Knura M; Garczorz W; Borek A; Drzymała F; Rachwał K; George K; Francuz T
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921222
[TBL] [Abstract][Full Text] [Related]
9. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer.
Hirata Y; Shiota M; Kobayashi T; Kashiwagi E; Takeuchi A; Inokuchi J; Tatsugami K; Eto M
Prostate Int; 2019 Dec; 7(4):166-170. PubMed ID: 31970142
[TBL] [Abstract][Full Text] [Related]
11. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
12. Drug Repositioning for Effective Prostate Cancer Treatment.
Turanli B; Grøtli M; Boren J; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Front Physiol; 2018; 9():500. PubMed ID: 29867548
[TBL] [Abstract][Full Text] [Related]
13. Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.
Qi C; Zhou Q; Li B; Yang Y; Cao L; Ye Y; Li J; Ding Y; Wang H; Wang J; He X; Zhang Q; Lan T; Lee KK; Li W; Song X; Zhou J; Yang X; Wang L
Oncotarget; 2014 Oct; 5(20):9966-79. PubMed ID: 25294818
[TBL] [Abstract][Full Text] [Related]
14. Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
Mao G; Zheng S; Li J; Liu X; Zhou Q; Cao J; Zhang Q; Zheng L; Wang L; Qi C
Anticancer Agents Med Chem; 2022; 22(9):1735-1741. PubMed ID: 34515012
[TBL] [Abstract][Full Text] [Related]
15. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
16. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
18. Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
Qi C; Bin Li ; Yang Y; Yang Y; Li J; Zhou Q; Wen Y; Zeng C; Zheng L; Zhang Q; Li J; He X; Zhou J; Shao C; Wang L
Sci Rep; 2016 Jun; 6():27819. PubMed ID: 27292155
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
